BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24011597)

  • 1. [The role of whole brain radiotherapy with hippocampal-sparing].
    Truc G; Martin É; Mirjolet C; Chamois J; Petitfils A; Créhange G
    Cancer Radiother; 2013 Oct; 17(5-6):419-23. PubMed ID: 24011597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.
    Prokic V; Wiedenmann N; Fels F; Schmucker M; Nieder C; Grosu AL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):264-70. PubMed ID: 22516808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
    Korkmaz Kirakli E; Oztekin O
    Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal sparing in stereotactic radiotherapy for brain metastases: To contour or not contour the hippocampus?
    Di Carlo C; Trignani M; Caravatta L; Vinciguerra A; Augurio A; Perrotti F; Di Tommaso M; Nuzzo M; Giancaterino S; Falco MD; Genovesi D
    Cancer Radiother; 2018 Apr; 22(2):120-125. PubMed ID: 29576492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.
    Hsu F; Carolan H; Nichol A; Cao F; Nuraney N; Lee R; Gete E; Wong F; Schmuland M; Heran M; Otto K
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1480-5. PubMed ID: 19625140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.
    Harth S; Abo-Madyan Y; Zheng L; Siebenlist K; Herskind C; Wenz F; Giordano FA
    Radiother Oncol; 2013 Oct; 109(1):152-8. PubMed ID: 24100152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the probability of underdosing microscopic brain metastases with hippocampal-sparing whole-brain radiation.
    Chang JS; Perez-Andujar A; Barani IJ; Ma L; Larson DA
    Radiother Oncol; 2016 Aug; 120(2):248-52. PubMed ID: 27406442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment.
    Kim KS; Wee CW; Seok JY; Hong JW; Chung JB; Eom KY; Kim JS; Kim CY; Park YH; Kim YJ; Kim IA
    Radiat Oncol; 2018 Feb; 13(1):29. PubMed ID: 29463267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy.
    Miura K; Kurosaki H; Utsumi N; Sakurai H
    Technol Cancer Res Treat; 2021; 20():1533033820986824. PubMed ID: 33641531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
    Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
    Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive evaluation during brain radiotherapy in adults: a simple assessment is possible].
    Taillia H; Bompaire F; Jacob J; Noël G
    Cancer Radiother; 2013 Oct; 17(5-6):413-8. PubMed ID: 24007953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
    Kundapur V; Ellchuk T; Ahmed S; Gondi V
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
    Zhao R; Kong W; Shang J; Zhe H; Wang YY
    Clin Lung Cancer; 2017 Mar; 18(2):127-131. PubMed ID: 28340924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation.
    Ghia A; Tomé WA; Thomas S; Cannon G; Khuntia D; Kuo JS; Mehta MP
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):971-7. PubMed ID: 17446005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int j radiat oncol biol phys 2010;78:1244-1252).
    Knisely JP; Yu JB
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):957-8; author reply 958. PubMed ID: 21281899
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
    Slade AN; Stanic S
    Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy for brain metastases].
    Latorzeff I; Antoni D; Gaudaire-Josset S; Feuvret L; Tallet-Richard A; Truc G; Noël G
    Cancer Radiother; 2016 Sep; 20 Suppl():S80-7. PubMed ID: 27523410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.